Search
Search Constraints
You searched for: Author/Creator Malik, Jonaid Ahmad- Malik, Jonaid Ahmad [remove] 6
- 614.4 4
- Communicable diseases -- Periodicals 4
- Epidemiology -- Periodicals 4
- Medical microbiology -- Periodicals 4
- Nosocomial infections -- Prevention -- Periodicals 4
- Public health -- Periodicals 4
- 547 1
- 615.19 1
- ACE2 Angiotensin-converting enzyme receptor 2 -- GISAID Global Initiative on Sharing All Influenza Data -- CDC Centre for Disease Control and Prevention -- VOI Variant of Interest -- VOC Variant of Concern -- VOHC Variant of High Consequence -- CMV Cytomegalovirus -- NIAID National Institute of Allergy and Infectious Diseases -- COVE Coronavirus Efficacy -- PHE Public Health Emergency -- EUAL Emergency Use Assessment and Listing -- RCT Randomised clinical trials -- SAE Serious adverse events -- CNBG China National Biotec Group -- BIBP Beijing Institute of Biological Products -- WIBP Wuhan Institute of Biological Products -- ADDE antibody dependent disease enhancement -- NERVTAG New and Emerging Respiratory Virus Threats Advisory Group -- WGS Whole-genome sequencing -- SIADP Sharing all influenza data platform -- HPVV Human papillomavirus vaccine -- RVZV Recombinant varicella-zoster vaccine -- HBV Hepatitis B virus vaccine -- NTD N-terminal domain -- RBD Receptor-binding domain 1
- ACE2 angiotensin-converting enzyme-2 -- ADRP ADP ribose-1′-phosphatase -- ARTES Germany: based biotechnology company specialized in recombinant protein production and process development from microbial expression systems -- BIOCAD BIO computer aided design RNA -- CanVirex AG Swiss Biotech Association -- CARDS Covid 19 acute respiratory distress syndrome -- CBC complete blood count -- CCHFV Crimean-Congo hemorrhagic fever virus -- CDC center for disease control and prevention -- CEA carcinoembryonic antigen -- CHIKV chikungunya virus -- CMV cytomegalovirus -- CNBG China National Biotec Group -- CNRS centre national de la recherche scientifique -- COPD chronic obstructive pulmonary disease -- COVID-19 corona virus disease 2019 -- CPAP continuous positive airway pressure -- CRP C-reactive protein -- DMVs double-membrane vesicles -- DWRAIR Diseases/Walter Reed Army Institute of Research -- DZIF German Center for Infection Research -- EBOV Ebola virus -- ECDC European Centre for Disease Prevention and Control -- ERGIC endoplasmic reticulum- golgi intermediate compartment -- ExoN exoribonuclease -- FiO2 fraction of inspired oxygen -- GCIR German Center for Infection Research -- GMV glycine mosaic virus -- GLA glucopyranosyl Lipid A -- GPO Government Pharmaceutical Organization -- HeV hepatitis virus E -- HBV hepatitis B virus -- HFNC high-flow nasal cannula -- HLC high lung compliance -- IAVI international AIDS vaccine initiative -- IDIBAPS Pi i Sunyer Biomedical Research Institute -- IEM Institute For Engineering in Medicine -- InfA influenza virus-A -- INRAE National Research Institute for Agriculture, Food and Environment -- IPV inactivated polio virus -- IMV Instruments de Médecine Vétérinaire -- LASSA lassa virus -- LASV lassa mammarenavirus -- LinKinVax French biotechnology startup that focuses on speeding up vaccine -- LiteVax BV spike-based (epitope screening) -- LLC low lung compliance -- LVVV live viral vectored vaccine -- MARV Marburg virus -- MDA5 melanoma differentiation associated protein -- MERS-CoV Middle East Respiratory Syndrome coronavirus -- MIGAL Galilee Research Institute Ltd -- MMR measles mumps rubella -- MVA modified vaccinia virus Ankara -- NERVTAG new and emerging respiratory virus Threats advisory group -- NiV Nippa virus -- NIV non-invasive ventilation -- NLC nanostructured Lipid Carriers -- NORV norovirus -- NSCLC non-small cell lung cancer -- NSP non-Structural proteins -- O-MT O-methyl transferase-2 -- OMV outer membrane vesicle -- ORFs open reading frames -- Osivax clinical stage biotechnology company -- P.C. preclinical -- PaCO2 partial pressure of carbon dioxide -- PaO2 partial pressure of oxygen -- PEEP positive end-expiratory pressure -- PPI proton pump inhibitors -- RBD receptor-binding domain -- RVF Rift Valley fever -- RdRp RNA dependent RNA polymerase -- RTC replication transcription complex -- RTI respiratory tract infections -- SARS-CoV-2 severe acute respiratory syndrome coronavirus-2 -- SIG SARS-COV-2 Interagency Group -- SpO2 oxygen saturation -- SRC VB VECTOR State Research Centre of Virology and Biotechnology -- TMPRSS2 transmembrane protein serine 2 -- TRSs transcriptional regulatory sequences -- USAMRIID/WARIAR United States Army Medical Research Institute of Infectious -- VEE Venezuelan equine encephalitis -- VLP virus like particle -- VOC variant of concern -- VOHC variant of high consequences -- VOI variant of interest -- VRI Vaccine Research Institute -- VSV vesicular stomatitis virus 1